ROCKVILLE, MD
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS, founded in 1933, is a community nonprofit in the Health Care sector that reported $5.7M in total revenue in fiscal year 2023. Revenue surged 28% from the prior year, signaling strong growth momentum. Expenses of $7.1M exceeded revenue, resulting in a 25% operating deficit.
THE AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (ASPET) IS A 4,000 MEMBER SCIENTIFIC SOCIETY WHOSE MEMBERS CONDUCT BASIC AND CLINICAL PHARMACOLOGICAL RESEARCH AND WORK FOR ACADEMIA, GOVERNMENT, LARGE PHARMACEUTICAL COMPANIES, SMALL BIOTECH COMPANIES, AND NON-PROFIT ORGANIZATIONS.
PUBLICATIONS - THE SOCIETY PUBLISHES SCIENTIFIC AND EDUCATIONAL JOURNALS AND OTHER PUBLICATIONS FOR THE SCIENTIFIC COMMUNITY INCLUDING THE FOLLOWING:JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL...
PUBLICATIONS - THE SOCIETY PUBLISHES SCIENTIFIC AND EDUCATIONAL JOURNALS AND OTHER PUBLICATIONS FOR THE SCIENTIFIC COMMUNITY INCLUDING THE FOLLOWING:JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS - MONTHLY RESEARCH PUBLICATION COVERING TOPICS INCLUDING THE INTERACTIONS OF CHEMICALS WITH BIOLOGICAL SYSTEMS, INCLUDING AUTONOMIC, BEHAVIORAL, CARDIOVASCULAR, CELLULAR, CLINICAL, DEVELOPMENTAL, GASTROINTESTINAL, IMMUNO-, NEURO-, PULMONARY AND RENAL PHARMACOLOGY, AS WELL AS ANALGESICS, DRUG ABUSE, METABOLISM AND DISPOSITION, CHEMOTHERAPY, AND TOXICOLOGY.PHARMACOLOGICAL REVIEWS - QUARTERLY REVIEW JOURNAL COVERING CONCENTRATIONS IN PHARMACOLOGY, EXPERIMENTAL THERAPEUTICS, TOXICOLOGY, AND CHEMOTHERAPY.MOLECULAR PHARMACOLOGY - MONTHLY PUBLICATION WITH AN EMPHASIS ON RESEARCH OF DRUG ACTION AND SELECTIVE TOXICITY AT THE MOLECULAR LEVEL. ORIGINAL APPLICATIONS OF BIOCHEMISTRY, BIOPHYSICS, GENETICS AND MOLECULAR BIOLOGY ARE COMBINED WITH PHARMACOLOGIC RESEARCH TO SOLVE BASIC PROBLEMS IN PHARMACOLOGY AND TOXICOLOGY.DRUG METABOLISM AND DISPOSITION - MONTHLY PUBLICATION COVERING THE FIELDS OF PHARMACOKINETICS, PHARMACODYNAMICS AND MECHANISMS, GENETIC NUTRITIONAL OR HORMONAL FACTORS AFFECTING THE BIOLOGICAL FATE OF CHEMICALS, AND THE TOXICOLOGICAL CONSEQUENCES OF XENOBIOTIC METABOLISM.THE PHARMACOLOGIST - QUARTERLY PUBLICATION WITH THE PURPOSE OF INFORMING PHARMACOLOGISTS ABOUT SOCIETY AFFAIRS AND OTHER MATTERS OF PROFESSIONAL INTEREST. DISTRIBUTED ELECTRONICALLY TO ASPET MEMBERS AND MAILED TO NONMEMBER SUBSCRIBERS AS WELL AS MEMBERS WHO PAY FOR A PRINT SUBSCRIPTION.
MEETINGS - THE SOCIETY HOSTS AN ANNUAL MEETING EACH YEAR IN A DIFFERENT PART OF THE US PROVIDING A FORUM FOR SCIENTISTS TO COMMUNICATE AND EXCHANGE PHARMACOLOGICAL KNOWLEDGE THROUGH SCIENTIFIC...
MEETINGS - THE SOCIETY HOSTS AN ANNUAL MEETING EACH YEAR IN A DIFFERENT PART OF THE US PROVIDING A FORUM FOR SCIENTISTS TO COMMUNICATE AND EXCHANGE PHARMACOLOGICAL KNOWLEDGE THROUGH SCIENTIFIC SESSIONS. SMALLER FOCUSED MEETINGS ARE HELD ON AN OCCASIONAL BASIS AS THE NEED ARISES.
AWARDS - THE SOCIETY OFFERS THREE TYPES OF AWARDS TO DISTINGUISHED PHARMACOLOGISTS AND TO STUDENTS AND YOUNG SCIENTISTS IN THE FIELD. SCIENTIFIC AWARDS ARE PROVIDED TO RECOGNIZE AND ENCOURAGE...
AWARDS - THE SOCIETY OFFERS THREE TYPES OF AWARDS TO DISTINGUISHED PHARMACOLOGISTS AND TO STUDENTS AND YOUNG SCIENTISTS IN THE FIELD. SCIENTIFIC AWARDS ARE PROVIDED TO RECOGNIZE AND ENCOURAGE OUTSTANDING RESEARCH BY PROMINENT PHARMACOLOGISTS AND TO STIMULATE FUNDAMENTAL RESEARCH BY YOUNG INVESTIGATORS. BEST POSTER AWARDS ARE PRESENTED TO MEETING ATTENDEES WHO HAVE SUBMITTED AN OUTSTANDING RESEARCH ABSTRACT FOR PRESENTATION AT THE MEETING. TRAVEL AWARDS ARE GRANTED TO STUDENTS AS AN EDUCATIONAL TOOL TO ATTEND SCIENTIFIC MEETINGS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $5,712,373 | $4,463,274 | +0.3% |
| Expenses | $7,144,205 | $5,114,519 | +0.4% |
| Net Income | $-1,431,832 | $-651,245 | +1.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| XINXIN DING | SEC/TREAS ELECT, THEN SEC/TREAS | 5.00 |
Officer
Director
|
$35,000 | $0 | $35,000 |
| MICHAEL L JARVIS | PRESIDENT, THEN PAST PRESIDENT | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| NAMANDJE BUMPUS | PRESIDENT ELECT, THEN PRESIDENT | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| MARGARET GNEGY | PAST PREDIDENT | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| KATHRYN CUNNINGHAM | SEC/TREAS, THEN PAST SEC/TREAS | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| CAROL BECK | PAST SEC/TREAS, THEN PRES ELECT | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| PAM HORNBY | SEC/TREAS ELECT | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| RANDY HALL | COUNCILOR | 5.00 |
Director
|
$0 | $0 | $0 |
| JOHN TRAYNOR | COUNCILOR | 5.00 |
Director
|
$0 | $0 | $0 |
| NINA ISOHERRANEN | COUNCILOR | 5.00 |
Director
|
$0 | $0 | $0 |
| DAVID JACKSON | EXECUTIVE OFFICER | 40.00 |
Officer
|
$305,502 | $10,959 | $316,461 |
| ROBERT STANLEY | CHIEF FINANCIAL OFFICER | 40.00 |
Officer
|
$203,566 | $40,419 | $243,985 |
| MELISSA HUSTON | MEETINGS DIRECTOR | 40.00 |
Highest
|
$150,741 | $28,675 | $179,416 |
| MARIA PASHO | JOURNAL DIRECTOR | 40.00 |
Highest
|
$161,777 | $22,365 | $184,142 |
| LYNNE HARRIS | MARKETING DIRECTOR | 40.00 |
Highest
|
$152,835 | $15,170 | $168,005 |
| CATHERINE FRY | EDUCATION DIRECTOR | 40.00 |
Highest
|
$152,636 | $33,727 | $186,363 |
| CARTER ALLEMAN | GOVT AFFAIRS & SCIENCE POL DIRECTOR | 40.00 |
Highest
|
$146,577 | $5,103 | $151,680 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $5,712,373 | $7,144,205 | $30,249,773 | $-1,431,832 |
| 2022 | $4,463,274 | $5,114,519 | $29,344,018 | $-651,245 |
| 2021 | $7,613,751 | $4,699,167 | $33,893,150 | $2,914,584 |
| 2020 | $4,904,674 | $4,608,155 | $30,160,576 | $296,519 |
| 2019 | $5,562,695 | $5,083,355 | $27,322,547 | $479,340 |
| 2018 | $5,505,934 | $5,134,580 | $22,578,825 | $371,354 |
Compare AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS with other nonprofits in Maryland and across the country.